WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹3.98 Cr | ₹20 Cr | ₹41 Cr | ₹17 Cr | ₹44 Cr |
What is the latest Cash Flow from Operating Activities ratio of WANBURY ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹3.98 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹41 Cr |
Mar2021 | ₹17 Cr |
Mar2020 | ₹44 Cr |
How is Cash Flow from Operating Activities of WANBURY Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹3.98 Cr | -79.91 | |
Mar2023 | ₹20 Cr | -51.15 | |
Mar2022 | ₹41 Cr | 142.91 | |
Mar2021 | ₹17 Cr | -62.20 | |
Mar2020 | ₹44 Cr | - |
Compare Cash Flow from Operating Activities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹826.4 Cr | -13.1% | -17.9% | 103.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹438,143.0 Cr | -1.2% | 0.9% | 41.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,578.0 Cr | -3.7% | -1.8% | 46.1% | Stock Analytics | |
CIPLA | ₹120,185.0 Cr | -1.5% | 2.2% | 16.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,450.0 Cr | 1.4% | 10.6% | 17.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,569.0 Cr | 3.5% | 3.6% | 37.4% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -13.1% |
-17.9% |
103.4% |
SENSEX | -2.9% |
-4.8% |
8% |
You may also like the below Video Courses